Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

nork Al-kali, Aref, Oswal, Alok, Tfayli, Arafat
Argitaratua 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

nork Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Argitaratua 2010

The Role of Monoclonal Antibodies in the Management of Leukemia

nork Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Argitaratua 2010

Competing cell clones in myeloproliferative neoplasm

nork Al-Kali, Aref, Verstovsek, Srdan, Kantarjian, Hagop, Luthra, Rajyalakshmi, Cortes, Jorge
Argitaratua izan da Blood (2010)

An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23

nork Song, Daisheng, Guan, Wei, Coon, Lea M, Al-Kali, Aref, Oliveira, Jennifer L, Lee, Frank S
Argitaratua izan da Hypoxia (Auckl) (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

nork Shen, Na, Yan, Fei, Pang, Jiuxia, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Argitaratua 2014

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

nork Al-Kali, Aref, Cortes, Jorge, Faderl, Stefan, Jones, Dan, Abril, Caroline, Pierce, Sherry, Brandt, Mark, Kantarjian, Hagop, Ravandi, Farhad
Argitaratua 2011

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

nork Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
Argitaratua izan da Syst Rev (2018)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

nork Yan, Fei, Al-Kali, Aref, Zhang, Zijie, Liu, Jun, Pang, Jiuxia, Zhao, Na, He, Chuan, Litzow, Mark R., Liu, Shujun
Argitaratua izan da Cell Res (2018)

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

nork Al-Kali, Aref, Kantarjian, Hagop, Shan, Jianqin, Bassett, Roland, Quintás-Cardama, Alfonso, Borthakur, Gautam, Jabbour, Elias, Verstovsek, Srdan, O’Brien, Susan, Cortes, Jorge
Argitaratua izan da Cancer (2010)

Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia

nork Shen, Na, Yan, Fei, Pang, Jiuxia, Zhao, Na, Gangat, Naseema, Wu, Laichu, Bode, Ann M., Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Argitaratua izan da Clin Cancer Res (2017)

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

nork Al-Kali, Aref, Konoplev, Sergej, Lin, Erpei, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Ayoubi, Mohamad, Brandt, Mark, Cortes, Jorge E., Kantarjian, Hagop, Borthakur, Gautam
Argitaratua 2012

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

nork Yang, Xiaojuan, Pang, Jiuxia, Shen, Na, Yan, Fei, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Peng, Yong, Lee, Robert J., Liu, Shujun
Argitaratua izan da Oncotarget (2016)

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

nork Osman, Mazen, Akkus, Zeynettin, Jevremovic, Dragan, Nguyen, Phuong L., Roh, Dana, Al-Kali, Aref, Patnaik, Mrinal M., Nanaa, Ahmad, Rizk, Samia, Salama, Mohamed E.
Argitaratua izan da J Clin Med (2021)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal orig...

nork Patnaik, Mrinal M., Lasho, Terra, Howard, Matthew, Finke, Christy, Ketterling, Rhett L., Al-Kali, Aref, Pardanani, Animesh, Droin, Nathalie, Gangat, Naseema, Tefferi, Ayalew, Solary, Eric
Argitaratua izan da Blood Cancer J (2018)

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

nork Patnaik, Mrinal M., Lasho, Terra, Padron, Eric, McCullough, Kristen, Al‐kali, Aref, Tefferi, Ayalew, Zeidan, Amer M., Gangat, Naseema, Savona, Michael, Steensma, David P., Solary, Eric
Argitaratua izan da Am J Hematol (2020)

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

nork Tefferi, Ayalew, Lasho, Terra L., Jimma, Thitina, Finke, Christy M., Gangat, Naseema, Vaidya, Rakhee, Begna, Kebede H., Al-Kali, Aref, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh
Argitaratua 2012

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

nork Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
Argitaratua izan da J Hematol Oncol (2015)

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine

nork Sterner, Rosalie M., Kremer, Kimberly N., Al-Kali, Aref, Patnaik, Mrinal M., Gangat, Naseema, Litzow, Mark R., Kaufmann, Scott H., Westendorf, Jennifer J., van Wijnen, Andre J., Hedin, Karen E.
Argitaratua izan da Oncotarget (2017)

Momelotinib therapy for myelofibrosis: a 7-year follow-up

nork Tefferi, Ayalew, Barraco, Daniela, Lasho, Terra L., Shah, Sahrish, Begna, Kebede H., Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Argitaratua izan da Blood Cancer J (2018)